Genetic and epigenetic changes in nasopharyngeal carcinoma

Seminars in Cancer Biology

Volumn 12, Issue 6, 2002, Pages 451-462

  Lo, Kwok Wai ^a   Huang, Dolly P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epstein Barr virus; Methylation; Nasopharyngealcarcinoma; Pathogenesis; Tumour suppressor gene

Indexed keywords

APOPTOSIS; CANCER GENETICS; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONFERENCE PAPER; CYTOGENETICS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; HUMAN; METHYLATION; NASOPHARYNX CARCINOMA; ONCOGENE; ONCOGENE RAS; PATHOGENESIS; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

EID: 0036433743     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044579X02000883     Document Type: Conference Paper

References (96)

1. Jeannel D, Bouvier G, Huber A (1999) Nasopharyngeal carcinoma: An epidemiological approach to carcinogenesis. Cancer Surv 33:125-155
2. McDermott AL, Dutt SN, Watkinson JC (2001) The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol 26:82-92
3. Hildesheim A, Levine PH (1993) Etiology of nasopharyngeal carcinoma: A review. Epidemiol Rev 15:466-485
4. Lo KW, Huang DWSP, Lee J (1997) Genetic changes in nasopharyngeal carcinoma. Chin Med J 110:548-559
5. Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS (1995) Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: Results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 4:607-610
6. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chhabra SK (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 89:1207-1212
7. Narar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM (1999) Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 8:547-551
8. Goldsmith DB, West TM, Morton R (2002) HLA associations with nasopharyngeal carcinoma in Southern Chinese: A meta-analysis. Clin Otolaryngol 27:61-67
9. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, Simons M, McKnight B, Easton D, Yi Z, DeThe G (1990) Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346:470-471
10. Wong N, Hui A, Fan B, Lo KW, Pang E, Leung SF, Huang DWS, Johnson PJ (2002) Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Lab Invest (in press)
11. Chen YJ, Ko JY, Chen PJ, Shu CH, Hsu MT, Tsai SF, Lin CH (1999) Chromosomal aberrations in nasophayngeal carcinoma analysed by comparative genomic hybridization. Genes Chromosomes Cancer 25:169-175
12. Hui ABT, Lo KW, Leung SF, Teo P, Fung MKF, To KF, Wong N, Choi PHK, Lee JCK, Huang DP (1999) Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 82:498-503
13. Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ, Huang DP (2000) Frequent c-myc and Int-2 over-representations in nasopharyngeal carcinoma. Human Pathol 31:169-178
14. Fang Y, Guan XY, Guo Y, Sham JST, Deng M, Liang Q, Li H, Zeng H, Zhou H, Trent J (2001) Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Gense Chromosomes Cancer 30:254-260
15. Chien G, Yuen PW, Kwong D, Kwong YL (2001) Comparative genomic hybridization analysis of nasopharyngeal carcinoma: Consistent patterns of genetic aberrations and clinicopathological correlations. Cancer Genet Cytogenet 126:63-67
16. Hui AB, Lo KW, Teo PM, To KF, Huang DP (2002) Genome-wide detection of oncogene amplifications in nasopharyngeal carcinoma by array-based comparative genomic hybridization. Int J Oncol 20:467-473
17. Mutirangura A, Tanunyuthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S, Supiyaphun P, Voravud N (1997) Genomic alterations in nasopharyngeal carcinoma: Loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 76:770-776
18. Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX, Yu XJ, Li JT, Hu LF, Ernberg I, Zeng YX (2000) Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 17:1267-1275
19. Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX (2001) Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 21:3021-3029
20. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC, Huang DP (2000) High-resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60:3348-3353
21. Fung LF, Lo AK, Yuen PW, Liu Y, Wang XH, Tsao SW (2000) Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 67:923-936
22. Xie L, Xu L, He Z, Zhou W, Wang L, Zhang L, Lan K, Ren C, Liu W, Yao K (2000) Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array. J Cancer Res Clin Oncol 126:400-406
23. Chan ASC, To KF, Lo KW, Mak KF, Pak W, Chiu B, Tse GMK, Ding M, Li X, Lee JCK, Huang DP (2000) High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60:5365-5370
24. Huang DP, Lo KW, Choi PH, Ng AY, Tsao SY, Yiu GK, Lee JC (1991) Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet 54:91-99
25. Lo KW, Tsao SW, Leung SF, Choi PHK, Lee JCK, Huang DP (1994) Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinomas. Int J Oncol 4:1359-1364
26. Hu LF, Eiriksdottir G, Lebedeva T, Kholodniouk I, Alimov A, Chen F, Luo Y, Zabarovsky ER, Ingvarsson S, Klein G, Ernberg I (1996) Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer 17:118-126
27. Deng L, Jing N, Tan G, Zhou M, Zhan F, Xie Y, Cao L, Li G (1998) A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 23:21-25
28. Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ (1998) Functional evidence for a nasopharyngeal carcinoma tumour suppressor gene that maps at chromosome 3p21.3
29. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61:3877-3881
30. Lerman MI, Minna JD (2000) Tumour suppressor gene consortium. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumour suppressor genes. Cancer Res 60:6116-6133
31. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP (2000) Epigenetic inactivation of a Ras association domain family protein from the lung tumour suppressor locus 3p21.3h. Nat Genet 25:315-319
32. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky ER, White M, Minna JD (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93:691-699
33. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER (2001) The candidate tumour suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumourigenesis. Proc Natl Acad Sci USA 98:7504-7509
34. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP, Avruch J (2002) The putative tumour suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21:1381-1390
35. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ (2000) Ras uses the novel tumour suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275:35669-35672
36. Croce CM, Sozzi G, Huebner K (1999) Role of FHIT in human cancer. J Clin Oncol 17:1618-1624
37. Ohta M, Hiroshi I, Cotticelli MG et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597
38. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K (1997) Structure and expression of the human FHIT gene in normal and tumour cells. Cancer Res 57:504-512
39. Sung NS, Zeng Y, Raab-Traub N (2000) Alterations on chromosome 3 in endemic and non-endemic nasopharyngeal carcinoma. Int J Cancer 86:244-250
40. Deng YF, Tian F, Lu YD, Chen ZC, Xie DH, Yang XM, Shao XY (2001) Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma. Laryngoscope 111:1589-1592
41. Sun Y, Hildesheim A, Li H, Lanier AP, Cao Y, Yao KT, Yang CS, Colburn NH (1995) The Von Hippel-Lindau (VHL) disease tumour suppressor gene is not mutated in nasopharyngeal carcinoma. Int J Cancer 60:437-438
42. Kwong J, Lo KW, To KF, Teo PML, Johnson PJ, Huang DP (2002) Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8:131-137
43. Wu S, Zhang D, Zhang ZP, Soprano DR, Soprano K (1998) Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid. Oncogene 17:2839-2849
44. Lam PK, To EW, Chan ES, Liew CT, Lung IW, King WK (2001) In vitro inhibition of head and neck cancer cell growth by human recombinant interferon-alpha and 13-cis retinoic acid. Br J Biomed Sci 58:226-229
45. Huang DP, Lo KW, van Hasselt CA, Woo JKS, Choi PHK, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JCK (1994) A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54:4003-4006
46. Lo KW, Huang DP, Lau KM (1995) p16 gene alterations in naospharyngeal carcinoma. Cancer Res 55:2039-2043
47. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH(1994) A cell cycle regulator potentially involved in genesis of many tumour types. Science 264:436-439
48. Sherr CJ (2000) The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 60:3689-3695
49. Lo KW, Cheung ST, Leung SF, van Hasselt A, Tsang YS, Mak KF, Chung YF, Woo JK, Lee JC, Huang DP (1996) Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 56:2721-2725
50. Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J (1998) Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumour suppressor protein but consistently express the retinoblastoma gene product. Am J Pathol 152:865-869
51. Wang GL, Lo KW, Tsang KS, Chung NYF, Tsang YS, Cheung ST, Lee JCK, Huang DP (1999) Inhibiting tumourigenic potential by restoration of p16 in nasopharyngeal carcinoma. Br J Cancer 81:1122-1126
52. Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI, Lung ML (2000) A functional investigation of tumour suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chromosomes Cancer 28:82-91
53. Chow LS, Wang X, Kwong DL, Sham JS, Tsao SW, Nicholls JM (2000) Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells. Int J Oncol 17:135-140
54. Cheng Y, Chakrabart R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ, Lung ML (2002) Mapping of nasopharyngeal carcinoma tumour-suppressive activity to a 1.8-megabase region of chromosome band 11q13. Genes Chromosomes Cancer 34:97-103
55. Hui ABY, Lo KW, Leung SF, Choi PHK, Fong Y, Lee JCK, Huang DP (1996) Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56:3225-3229
56. Hui AB, Lo KW, Chan SY, Kwong J, Chan AS, Huang DP (2002) Absence of SDHD mutations in primary nasopharyngeal carcinomas. Int J Cancer 97:875-877
57. Hui AB, Lo KW, Kwong J, Teo PM, Lam EC, Chan YY, To KF, Chow LS, Chan AS, Huang DP (2002) Silencing of TSLC1 Gene Expression by Promoter Hypermethylation in Nasopharyngeal Carcinoma (submitted for publication)
58. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, Murakami Y (2001) TSLC1 is a tumour suppressor gene in human non-small cell lung cancer. Nature Genet 27:427-430
59. Allinen M, Peri L, Kujala S, Lahti-Domenici J, Outila K, Karppinen, Launonen V, Winqvist R (2002) Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: Indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer (in press)
60. Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F, Arai K, Aikawa Y, Tsuda H, Hirohashi S, Asakawa S, Shimizu N, Soeda E, Sakaki Y, Ohki M (1999) A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics 62:139-146
61. Tsang YS, Lo KW, Leung SF, Choi PHK, Fong Y, Lee JCK, Huang DP (1999) Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 83:305-308
62. Sun Y, Hegamyer G, Colburn NH (1993) Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene 8:791-795
63. Lo KW, Tsang YS, Kwong J, To KF, Teo PML, Huang DP. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 98:651-655
64. Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW (1996) Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56:663-668
65. Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E, Richards RI (2000) Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res 60:1683-1689
66. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, Tsao SW (1999) Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis. Hum Pathol 30:458-466
67. Claudio PP, Howard CM, Fu Y, Cinti C, Califano L, Micheli P, Mercer EW, Caputi M, Giordano A (2000) Mutations in the retinoblastoma-related gene Rb2/p130 in primary nasopharyngeal carcinoma. Cancer Res 60:8-12
68. Gray SG, Guo X, Kedra D, Teh BT, Guo X, Min HQ (2001) Correspondence re: Claudio PP et al. Mutations in the retinoblastoma-related gene Rb2/p130 in primary nasopharyngeal carcinoma. Cancer Res 61:5950-5953
69. Rountree MR, Bachman KE, Herman JG, Baylin SB (2001) DNA methylation, chromatin inheritance, and cancer. Oncogene 20:3156-3165
70. Widschwendter M, Jones PA (2002) The Potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: Kwong J et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8:131-137
71. and Zou H-Z et al. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8:188-191, 8:17-21
72. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY (2002) Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787-794
73. Ambinder RF, Robertson KD, Tao Q (1999) DNA methylation and the Epstein-Barr virus. Semin Cancer Biol 9:369-375
74. Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW (2001) Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol 75:9753-9761
75. Yung WC, Sham JS, Choy DT, Ng MH (1995) Ras mutations are uncommon in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 31B:399-400
76. Qian W, Hu LF, Chen F, Wang Y, Magnusson KP, Kashuba E, Klein G, Wiman KG (1995) Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 31B:328-332
77. Lu QL, Elia G, Lucas S, Thomas JA (1993) Bcl2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29-35
78. Lai JP, Tong CL, Hong C, Xiao JY, Tao ZD, Zhang Z, Tong WM, Betz CS (2002) Association between high initial tissue levels of cyclin D1 and recurrence of nasopharyngeal carcinoma. Laryngoscope 112:402-408
79. Porter MJ, Field JK, Leung SF, Lo D, Lee JC, Spandidos DA, van Hasselt CA (1993) The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 114:105-109
80. Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT (2002) Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 62:589-596
81. Fujii M, Yamashita T, Ishiguro R, Tashiro M, Kameyama K (2002) Significance of epidermal growth factor receptor and tumour-associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 29:175-181
82. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21:99-102
83. Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, du Manoir S (2001) A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61:4122-4129
84. Crook T, Nicholls JM, Brooks L, O'Nions J, Allday MJ (2000) High level expression of deltaN-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19:3439-3444
85. Wang X, Jin DY, Wong YC, Cheung ALM, Chun ACS, Lo AKF, Liu Y, Tsao SW (2000) Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 21:2293-2297
86. Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Satake K, Koshika S, Nakatani Y, Hara M, Kato Y, Nagashima Y (2001) Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev 25:414-419
87. Wong TS, Chang HW, Tang KC, Wei WI, Kwong DLW, Sham JST, Yuen APW, Kwong YL (2002 Feb) High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Clin Cancer Res 8(2):433-437
88. Fries KL, Miller WE, Raab-Traub N (1996) Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 70:8653-8659
89. Codd JD, Salisbury JR, Packham G, Nicholson LJ (1999) A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol 187:549-555
90. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K (2002) Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 21:954-965
91. Jiang X, Yao KT (1996) The clonal progression in the neoplastic process of nasopharyngeal carcinoma. Biochem Biophys Res Commun 221:122-128
92. Sheu LF, Chen A, Meng CL, Ho KC, Lin FG, Lee WH (1997) Analysis of bcl2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: Association with p53 expression. Hum Pathol 28:556-562
93. Chang JT, Liao CT, Jung SM, Wang TC, See LC, Cheng AJ (2000) Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br J Cancer 82:1946-1951
94. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693-698
95. Chan ASC, To KF, Lo KW, Ding M, Li XH, Johnson P, Huang DP (2002) Frequent Chromosome 9p Losses in Histologically Normal Nasopharyngeal Epithelia from Southern Chinese (submitted for publication)
96. Speck P, Haan KM, Longnecker R (2000) Epstein-Barr virus entry into cells. Virology 277:1-5